文献速递脑血管病外科神经重症

治疗方式对蛛网膜下腔出血患者院内结局的影响:日本全国性研究(J-ASPECT研究)

Effect of treatment modality on in-hospital outcome in patients with subarachnoid hemorrhage: a nationwide study in Japan (J-ASPECT Study).
PubMed 文献 · J Neurosurg · 2017-05-26

该研究分析日本393家机构5214例蛛网膜下腔出血患者(夹闭3624例,栓塞1590例),比较两种治疗方式的院内结局。栓塞组院内死亡率显著高于夹闭组(12.4% vs 8.7%,OR 1.3),中位住院时间更短(32.0 vs 37.0天,p<0.001),而mRS 3-6分比例和医疗费用无显著差异。结论认为夹闭仍是主要治疗方式,与栓塞相比与更低院内死亡率相关。

要点

  • 栓塞组院内死亡率12.4% vs 夹闭组8.7%(OR 1.3),夹闭组更低。
  • 栓塞组中位住院时间32.0天 vs 夹闭组37.0天(p<0.001),栓塞组更短。
  • mRS 3-6分比例(46.4% vs 42.9%)和中位医疗费用(35.7 vs 36.7千美元)两组无显著差异。

核心结论

  • 尽管栓塞使用增加,夹闭仍是蛛网膜下腔出血的主要治疗方式。
  • 无论综合卒中中心能力如何,2012年日本数据中夹闭与栓塞相比与更低院内死亡率、相似的不良功能结局和医疗费用、以及更长住院时间相关。
  • 需要进一步研究以确定未测量混杂因素的影响。

研究设计与样本

  • 研究分析日本2012年4月至2013年3月期间393家机构急诊住院的5214例蛛网膜下腔出血患者(夹闭3624例,栓塞1590例)。
  • 采用混合模型分析比较夹闭组与栓塞组的院内死亡率、改良Rankin量表(mRS)评分、脑梗死、并发症、住院时间和医疗费用,并调整患者层面和医院层面特征。

主要发现

  • 栓塞组院内死亡率显著高于夹闭组(12.4% vs 8.7%,OR 1.3)。
  • 栓塞组中位住院时间显著短于夹闭组(32.0 vs 37.0天,p<0.001)。
  • 出院时mRS评分3-6分比例栓塞组46.4% vs 夹闭组42.9%,两组无显著差异。
  • 中位医疗费用栓塞组35.7千美元 vs 夹闭组36.7千美元,两组无显著差异。
  • 进一步调整综合卒中中心能力作为医院相关协变量后,结果保持稳健。

局限性

  • 需要进一步研究以确定未测量混杂因素的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Although heterogeneity in patient outcomes following subarachnoid hemorrhage (SAH) has been observed across different centers, the relative merits of clipping and coiling for SAH remain unknown. The authors sought to compare the patient outcomes between these therapeutic modalities using a large nationwide discharge database encompassing hospitals with different comprehensive stroke center (CSC) capabilities. METHODS They analyzed data from 5214 patients with SAH (clipping 3624, coiling 1590) who had been urgently hospitalized at 393 institutions in Japan in the period from April 2012 to March 2013. In-hospital mortality, modified Rankin Scale (mRS) score, cerebral infarction, complications, hospital length of stay, and medical costs were compared between the clipping and coiling groups after adjustment for patient-level and hospital-level characteristics by using mixed-model analysis. RESULTS Patients who had undergone coiling had significantly higher in-hospital mortality (12.4% vs 8.7%, OR 1.3) and a shorter median hospital stay (32.0 vs 37.0 days, p < 0.001) than those who had undergone clipping. The respective proportions of patients discharged with mRS scores of 3-6 (46.4% and 42.9%) and median medical costs (thousands US$, 35.7 and 36.7) were not significantly different between the groups. These results remained robust after further adjustment for CSC capabilities as a hospital-related covariate. CONCLUSIONS Despite the increasing use of coiling, clipping remains the mainstay treatment for SAH. Regardless of CSC capabilities, clipping was associated with reduced in-hospital mortality, similar unfavorable functional outcomes and medical costs, and a longer hospital stay as compared with coiling in 2012 in Japan. Further study is required to determine the influence of unmeasured confounders.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kurogi R, Kada A, Nishimura K, et al. Effect of treatment modality on in-hospital outcome in patients with subarachnoid hemorrhage: a nationwide study in Japan (J-ASPECT Study). J Neurosurg. 2017. PMID: 28548595. doi:10.3171/2016.12.JNS161039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。